Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

The lauded Lasker Awards, frequently tied to Nobel Prize acclaim, highlighted the significant accomplishments of three ...

UK This study presents a valuable finding on the role of cholesterol-binding site on GLP-1 receptors and functionally characterizes the impact of this mutation on receptor behavior in the membrane and ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

MONDAY, Sept. 16, 2024 (HealthDay News) -- Fatty liver disease linked to diabetes and obesity can easily progress to liver ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

A weight loss drug has been found to be broadly safe and effective for children under 12 with obesity, according to a small ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the ...

A research team has found that lateral septum (LS) neurons play a crucial role in the anorectic and weight-lowering effects of liraglutide in mice, revealing that GLP-1 receptors in the LS mediate ...

Native GLP-1, however, is rapidly inactivated by dipeptidyl peptidase 4; therefore, a continuous infusion would be required to achieve a clinical effect. Liraglutide is a GLP-1 analog, which is ...

One piece of good news has been the development of medicines such as glucagon-like peptide 1 (GLP-1) receptor agonists. This class of drugs includes semaglutide (Ozempic, Wegovy), liraglutide ...